Key Takeaways CONMED reported Q4 adjusted EPS of $1.43, surpassing estimates on strong surgical segment performance.CNMD's Q4 revenue rose to $373.2 million, led by Orthopedic and General Surgery product line strength.CONMED's gross margin expanded 116 bps to 58.5%, reflecting improved profitability in Q4.CONMED Corporation (CNMD) delivered adjusted earnings per share (EPS) of $1.43 in the fourth quarter of 2025, up 6.7% year over year. The figure beat the Zacks Consensus Estimate by 8.6%.The adjustments in ...

CONMED (NYSE:CNMD) Q4 2025 Earnings call January 28, 2026 04:30 PM ET Company ParticipantsPatrick Beyer - President and CEOTodd Garner - EVP and CFOConference Call ParticipantsMatthew O'Brien - AnalystMike Matson - AnalystRobbie Marcus - AnalystTravis Steed - AnalystVik Chopra - AnalystYoung Li - AnalystOperatorGood day, and thank you for standing by. Welcome to CONMED's Fourth Quarter Fiscal 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's present ...